RecruitingPhase 2NCT07197866

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Principal Investigator
Teva Medical Expert, MD
Teva Branded Pharmaceutical Products R&D LLC
Intervention
TEV-56286(drug)
Enrollment
200 target
Eligibility
30 years · All sexes
Timeline
2025 – 2029

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07197866 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

See all trials for Multiple system atrophy →

← Back to all trials